Background: Tuberculosis (TB) remains an important cause of morbidity, the leading cause of death in patients with human immunodeficiency virus (HIV) infection, and a challenge to global public health. This study aimed to analyze the predictors associated with mortality among individuals coinfected with TB/HIV at a reference center in southeastern Brazil. Method: This retrospective cohort study used the data obtained from clinical records and information systems from 2007 to 2014. The data were analyzed using Cox proportional hazards model to identify the independent predictors. Results: Among the 924 individuals studied, 72.7 % were men. The median age was 38 years (range: 16-78 years). The mortality rate was 21.6%. The predictors associated with mortality were as follows: Results demonstrated that patients coinfected with TB/HIV have high mortality rates. Therefore, it is necessary to address the social determinants of health to provide every individual an equal opportunity to gain access to healthcare to cope with TB/HIV coinfection.
INTRODUCTION
HIV infection is one of the risk factors for tuberculosis (TB) in individuals infected with Mycobacterium tuberculosis (M. tuberculosis). 1 The synergy between M. tuberculosis and human immunodeficiency virus (HIV) has an impact on the natural history, epidemiology, economy, politics, molecular biology and clinical evolution of both diseases and poses a challenge for public health. TB is the leading cause of morbidity and mortality in people living with HIV/AIDS (PLWHA). 2 Individuals infected with HIV are 21 to 34 times more likely to develop TB than are those without HIV. 3 HIV promotes the reactivation of latent M. tuberculosis infection for active TB owing to the patients' poor immune responses. 4 The initiation of antiretroviral therapy (ART) during TB treatment has significantly improved the survival of this population. Studies have shown that ART reduces the individual risk of developing TB by 65%, regardless of the number of CD4+ T lymphocytes. 5 However, people living with HIV/AIDS coinfected with TB have complexity in pharmacological treatment due to frequency of doses, long duration and toxicity of the drugs, [6] [7] as well as the behavioral factors of this population. 8 These factors may cause inadequate adherence to therapies, leading to therapeutic failure and decreased survival of these individuals. In Brazil, the average survival time of PLWHA after diagnosis has been altered because of several factors, such as access to treatment and the inclusion of new pharmacological groups and formulations such as fixeddose combinations. During the 1980s and 1990s, the average survival time of PLWHA was 5 months. 9 This average increased to 18 months and 58 months in 1995 and 1996, respectively. 10 In 2002, the average survival time was reported to be 7 years.
11 Different factors affect the survival rate of individuals with TB/HIV coinfection in developing countries such as Brazil. These factors include age, sex, marital status, education level, religion, occupation, residence, body weight, clinical presentation of TB, 12-13 abandonment of TB treatment, CD4+ T lymphocyte count ≤200 cells/mm 3 , low wages, smoking, alcohol consumption, previous TB treatment and illiteracy. 5, [14] [15] [16] However, the average survival time of individuals coinfected with TB/ HIV has not been well studied in Brazil. Thus, knowledge on survival time in this population can provide indicators for control actions and planning interventions that can reduce the mortality in this population. This study aimed to analyze the mortality rate of patients coinfected with TB/HIV and its associated factors.
MATERIALS AND METHODS

Study design
This retrospective cohort study used the data obtained from clinical records and notifications from January 1, 2007 to December 31, 2014. 3 ) and 17.3% had an undetectable one. With regard to treatment, 81.7% of the individuals used ART, whereas 82.5% used anti-TB drugs. In 2014, the largest TB/HIV coinfection registry occurred. The highest number of deaths occurred in 2007 (36.1%), followed by the year 2010 (29.3%). The demographic and clinical characteristics of the study participants are presented in Table 1 . During the study period, 1,603 person-years were at risk (1,135 and 468 for men and women, respectively) and 200 died. The mortality rate of the cohort was 21.6%. The death toll ratio was 12.5/100 person-years, that is, 8.48/100 person-years for men and 3.99/100 person-years for women. The average survival time was 83 months (95% CI: 79.3-86.1). The Kaplan-Meier survival curves according to age, CD4+ T lymphocyte cell count, viral load and ART used are shown in Figure 1 . In the adjusted multivariate analysis (Table 2 ), the mortality risk was 2.5 times higher among individuals aged over 50 years. Individuals with a CD4+ T cell lymphocyte count of <200 cells/mm 3 had a 1.4-fold greater risk of mortality than those with CD4+ T lymphocytes >200 cells/mm 3 .
Predictors of Mortality among
Regarding the viral load, the risk was 1.73 for detectable individuals (>40 copies/mm 3 ). Individuals who did not use antiretroviral therapy had a 2.9-fold higher risk than those who used it.
DISCUSSION
This study showed a high mortality rate among individuals with TB/HIV coinfection at a reference center that specialized in the treatment of patients with infectious diseases in the State of Minas Gerais, Brazil. The mortality rate was higher among men and was positively associated with age above 50 years, CD4+ T lymphocyte count ≤200 cells/mm 3 , detectable viral load (>40 copies/mm 3 ) and non-use of ART. TB/HIV coinfection poses a challenge for developing countries with a high prevalence of TB. 19 In this study, TB remained the major caused of severe morbidity and death in individuals with HIV infection. Unlike other opportunistic diseases, TB may occur in individuals with HIV infection regardless of the degree of immunodeficiency. 20 The study was performed at the Eduardo de Menezes Hospital (EMH), which belongs to the public health network of Minas Gerais, southeastern Brazil. EMH provides specialized care services and is a reference center for the care of PLWHA. The services provided by EMH have regional and state strategic importance at the secondary and tertiary levels of complexity. This is the only hospital located in Belo Horizonte that plays an important role as part of the program for adequate integration of PLWHA in the Department of IST/HIV/AIDS and Viral Hepatitis of the Ministry of Health.
Study population
We included all individuals with concomitant TB and HIV/AIDS, regardless of their initial diagnosis, who were reported in the Epidemiology Hospital Center (EHC) and who received care in EMH within the study period. We considered TB cases, individuals who had a smear and/or culture positive for M. tuberculosis or those in whom the physician established a diagnosis of TB on the basis of the clinical and/or epidemiological data and the results of complementary tests regardless of its clinical form, according to the case definition recommended by the National Tuberculosis Control Program in Brazil. 17 We considered HIV infection cases, individuals who had positive screening and confirmatory tests from January 1, 2007, to December 31, 2014, according to the guidelines of the Brazilian Ministry of Health. 18 The database was constructed based on the data recorded in the EHC/ EMH, data obtained from the Medical File and Statistics Service (MFSS), records of patients being followed up in the reference hospital and data recorded in the following information systems: 1. Computerized System of Hospital Management, 2. System of Logistic Control of Medicines (SLCM) and 3. Laboratory Tests Control System of the National Network for CD4/CD8 T Lymphocyte Count and Viral Load (LTCS). We performed the analysis of inconsistencies after the construction of the database.
Variables
The survival time in months and occurrence of death or censoring were considered as response variables. The survival time was calculated in months, on the basis of the date of entry into the cohort and the date of death or censoring. For the analysis of death, the cases recorded in the EHC, MFSS and SLCM and confirmed in the Mortality Information System were considered. The explanatory variables were age, sex, skin color, municipality of residence, date of TB diagnosis, type of TB, use of anti-TB drugs, year when the patient was diagnosed with HIV, CD4+ T lymphocytes count, viral load count and ART use. For the variables CD4+ T lymphocyte count and viral load, the initial results of these tests were considered in the follow-up period.
Statistical analysis
A descriptive analysis of the population was performed using frequency distributions, central tendencies and dispersion measurements. Student's t-test was used to compare the mean differences of continuous variables, whereas Pearson's chi-square test was used to compare the proportions of categorical variables. The Kaplan-Meier nonparametric method was used to compute for the accumulated probability of survival times in patients coinfected with TB/HIV. The significance level was considered as <0.05. The magnitude of the association between the selected explanatory variables and the death event was estimated by the adjusted hazard ratio (AHR) with 95% confidence interval (CI), which was obtained using the Cox proportional There was a clear predominance of male patients in this study, which agrees with the findings other studies in the Brazilian context that observed a higher incidence and prevalence of TB/HIV among male patients. 5, 21 In addition, our findings showed a prevalence of coinfection among individuals aged 20-59 years, which is similar to the results of other studies. 22 Currently, the increase in the number of individuals with HIV infection, aged over 50 years, both in Brazil and in the world, can be detected and evaluated on the basis of demographic data, increase in the number of notifications and aging of the infected population. 23 The differences in skin color mentioned in the study population, with a higher prevalence of brown color, should be highlighted. This variable may have limitations in the self-perception of the individual and in the reliability of this information to fill out the notification forms. This result differs partially from other studies where the highest prevalence was in the black and brown population. Analysis of this variable has contributed to the understanding of the disadvantages and inequalities faced by the black population in accessing health care resources. 24 Moreover, about 48.2% of the individuals lived in urban regions; this may be due to the increased urbanization and the social and economic habits of the population in the last decades. Previous studies have showed that the predominant clinical form of TB was pulmonary and this result is consistent with that of other studies. 25 In this study, most of the participants used ART. Since the introduction of ART, a significant reduction in the progression of AIDS and the burden of opportunistic infections has been observed globally. 26 In this cohort, the risk of death in individuals who did not use ART was three times higher than that among individuals who used it. The use of ART reduces the incidence of TB by 65% in individuals with HIV infection. 27 The majority were using ART (81.7%), a similar result found in the study by Cunha et al. 28 In our cohort, 49.4% presented detectable viral load (>40 copies/mm 3 ). Recent studies have reported that viral suppression rates range from 65% to 80% according to different antiretroviral regimens. 29 Adherence to the treatment regimen is of paramount importance to achieve viral suppression. Viral suppression is greater in individuals with greater than 95% treatment adherence. Adherence to treatment greater than 95% results in reduction of viral resistance and an increase in the quality of life as well as survival. 30 The mortality rate (21.6%) reported in this study was higher than that reported in studies conducted in Europe (4.0%), Uganda (10.5%), Argentina and Latin America (11.0%) and Nigeria (16.6%). [31] [32] [33] Furthermore, between 2002 and 2012, the incidence of TB/HIV coinfection in Brazil increased by 3.8%, indicating a growing importance of HIV in TB epidemiology. 34 In our cohort, 49.4% presented detectable viral load (>40 copies/mm 3 ). Recent studies have reported that viral suppression rates range from 65% to 80% according to different antiretroviral regimens. 29 Adherence to the treatment regimen is of paramount importance to achieve viral suppression. Viral suppression is greater in individuals with greater than 95% treatment adherence. Adherence to treatment greater than 95% results in reduction of viral resistance and an increase in the quality of life as well as survival. 30 The mortality rate (21.6%) reported in this study was higher than that reported in studies conducted in Europe (4.0%), Uganda (10.5%), Argentina and Latin America (11.0%) and Nigeria (16.6%). [31] [32] [33] Furthermore, between 2002 and 2012, the incidence of TB/HIV coinfection in Brazil increased by 3.8%, indicating a growing importance of HIV in TB epidemiology.
34
CD4+ T lymphocyte count is a strong predictor of HIV progression and patient survival. This study showed that individuals with a CD4+ T lymphocyte count lesser 200 cells/mm 3 were more likely to die, which is similar to the results of other studies. 5, 35 A low CD4+ T lymphocyte count in patients with TB/HIV indicates that these patients were probably diagnosed late. Even with the incentive for the early diagnosis of HIV in Brazil, this is not yet the case and late diagnosis is a public health problem. 35 This study had some limitations. The study was conducted in a single reference hospital that provides treatment to patients with infectious diseases and outpatient care. The database included secondary information from notifications, medical records and information systems, which may lead to under-or overestimation of the analyses performed; additionally, some data were missing.
CONCLUSION
Although Brazilian patients have access to TB/HIV treatment, this study demonstrated a high proportion of TB/HIV coinfection and mortality. Factors associated with mortality risk were age above 50 years, count CD4+ T lymphocyte less than 200 cells/mm
